These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6102434)

  • 1. The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease.
    Burckhardt D; Raeder EA
    Am Heart J; 1980 Apr; 99(4):443-5. PubMed ID: 6102434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease.
    de Soyza N; Kane JJ; Murphy ML; Laddu AR; Doherty JE; Bissett JK
    Am Heart J; 1980 Nov; 100(5):631-8. PubMed ID: 6778183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-arrhythmic properties of acebutolol (Bay c 7705), a new cardioselective beta-adrenergic blocking agent: a preliminary report.
    Burckhardt K; Raeder E; Ebner F
    Curr Med Res Opin; 1977; 4(7):496-500. PubMed ID: 844327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E
    Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.
    Singh SN; DiBianco R; Davidov ME; Gottdiener JS; Johnson WL; Laddu AR; Fletcher RD
    Circulation; 1982 Jun; 65(7):1356-64. PubMed ID: 6176357
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of beta-blockade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias.
    Acanfora D; Pinna GD; Gheorghiade M; Trojano L; Furgi G; Maestri R; Picone C; Iannuzzi GL; Marciano F; Rengo F
    Am J Ther; 2000 Aug; 7(4):229-36. PubMed ID: 11486156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of ventricular arrhythmia by acebutolol.
    Santoso T; Nursyirwan EF; Trisnohadi HB; Manurung D; Rahman AM; Abdurahman N
    Clin Cardiol; 1983 Feb; 6(2):58-63. PubMed ID: 6831786
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
    Admon D; Kamchi A; Lewis BS; Gotsman MS
    Isr J Med Sci; 1979 Mar; 15(3):207-11. PubMed ID: 37190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acebutolol on left ventricular performance.
    Singh SN; DiBianco R; Katz RJ; Costello RB; Fletcher RD
    Am Heart J; 1985 May; 109(5 Pt 2):1151-6. PubMed ID: 2859779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of oral acebutolol and propranolol at rest and during exercise in ischemic heart disease: double-blind placebo crossover study utilizing radionuclide ventriculography.
    Kaul S; Hecht HS; Seidman R; Hopkins J; Singh BN
    Am Heart J; 1984 Sep; 108(3 Pt 1):469-74. PubMed ID: 6382987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the beta-blocking drug acebutolol in angina pectoris.
    Rod JL; Admon D; Kimchi A; Gotsman MS; Lewis BS
    Am Heart J; 1979 Nov; 98(5):604-12. PubMed ID: 495406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention by acebutolol of rhythm disorders following coronary bypass surgery.
    Materne P; Larbuisson R; Collignon P; Limet R; Kulbertus H
    Int J Cardiol; 1985 Jul; 8(3):275-86. PubMed ID: 3894250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study.
    De Soyza N; Shapiro W; Chandraratna PA; Aronow WS; Laddu AR; Thompson CH
    Circulation; 1982 Jun; 65(6):1129-33. PubMed ID: 7042111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer antiarrhythmic agents for patients with coronary artery disease.
    Schroeder JS
    Angiology; 1978 Jan; 29(1):22-32. PubMed ID: 343649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous acebutolol in supraventricular arrhythmias and ventricular extrasystole. Experience in 22 cases].
    Yenes A; Chamorro H; González G
    Rev Med Chil; 1984 Jan; 112(1):32-5. PubMed ID: 6204365
    [No Abstract]   [Full Text] [Related]  

  • 17. Acebutolol in supraventricular arrhythmias.
    Aronow WS; Van Camp S; Turbow M; Whittaker K; Lurie M
    Clin Pharmacol Ther; 1979 Feb; 25(2):149-53. PubMed ID: 365429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acebutolol in coronary heart disease: an ergometric double-blind study (author's transl)].
    Böhm H; Ludwig B
    Dtsch Med Wochenschr; 1980 Jul; 105(27):958-60. PubMed ID: 7408684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.
    Lui HK; Lee G; Dhurandhar R; Hungate EJ; Laddu A; Dietrich P; Mason DT
    Am Heart J; 1983 May; 105(5):722-6. PubMed ID: 6846115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sotalol on exercise-induced ventricular arrhythmias.
    Petzl DH; Probst P; Glogar D; Schuster E
    Eur Heart J; 1988 Mar; 9(3):265-70. PubMed ID: 3383867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.